The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Linnik Matthew D since 2006.
The trader's CIK number is 1237521.
At the time of the last reporting, Linnik Matthew D was the CSO & Exec VP of Res of La Jolla Pharmaceutical Co. (stock ticker symbol LJPC).
Also see all insider trading activities at La Jolla Pharmaceutical Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | LJPC | 0 | $0 | 5,365 | $15,495 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-12-21 | LJPC | Sale | 5,000 | 2.88 | 14,390 |
| 2006-12-27 | LJPC | Sale | 365 | 3.03 | 1,105 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Linnik Matthew D (CSO & Exec VP of Res of La Jolla Pharmaceutical Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.